April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 09, 2025

Oral Microbiome Linked to Chronic Pain in Women

Study finds poor oral health and oral pathobionts associated with pain in migraine, fibromyalgia, and abdominal disorders, suggesting possible treatment avenues.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 19, 2025

Study: Sex Differences in Physician Suicide

Researchers found that female physicians had a significantly higher suicide risk than female nonphysicians.

Conexiant

September 18, 2024

Do Hydrocephalus Shunts Pose Less Pregnancy Risk Than Once Thought?

A 2024 study of 85 pregnancies found no shunt malfunctions during pregnancy and only a 5.9% postpartum revision rate, contradicting decades of data on shunt failure risks for pregnant women.

Conexiant

June 06, 2024

Brain Changes Could Be Tied to Diet Quality, Study Suggests

Study finds that adherence to unhealthy diets is associated with changes in brain neurochemistry and structure.

Conexiant

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant

February 21, 2025

Examining Coprescription Trends Driving the Twin Epidemic

In a 10-year U.S. cohort study, researchers identified a strong association between stimulant coprescriptions and escalating opioid doses.

Conexiant

June 10, 2024

Melatonin May Reduce Age-related Macular Degeneration Risk

Melatonin use is associated with a reduced risk of developing and progressing age-related macular degeneration.

Conexiant